| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
APPaRENT 3: Asthma Patients’ and Physicians' Perspectives on the Burden and Management of Asthma in Seven Countries
|
Aggarwal, Bhumika
|
|
|
41 |
8 |
p. 3089-3118
|
artikel
|
| 2 |
A Response to: Letter to the Editor Regarding “Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs”
|
Gianesini, Sergio
|
|
|
41 |
8 |
p. 3439-3440
|
artikel
|
| 3 |
A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate–Severe Asthma
|
Garcia, Gabriel
|
|
|
41 |
8 |
p. 3196-3216
|
artikel
|
| 4 |
Association of Gastrointestinal Symptoms with Depression and Anxiety in Recruits: A Validation Cross-Sectional Study
|
Liu, Tingwei
|
|
|
41 |
8 |
p. 3173-3182
|
artikel
|
| 5 |
Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen® and Smart B® in Women with Climacteric Syndrome in Perimenopause
|
Kachko, Vera A.
|
|
|
41 |
8 |
p. 3183-3195
|
artikel
|
| 6 |
Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort
|
Heerspink, Hiddo
|
|
|
41 |
8 |
p. 3264-3277
|
artikel
|
| 7 |
Comparison Between Sotorasib with Docetaxel for the Treatment of Chinese Patients with Previously Treated NSCLC with KRASG12C Mutation: A Cost-Effectiveness Analysis to Inform Drug Pricing
|
Yi, Lidan
|
|
|
41 |
8 |
p. 3159-3172
|
artikel
|
| 8 |
Cost-effectiveness of Finerenone in Addition to Standard of Care for Patients with Chronic Kidney Disease and Type 2 Diabetes in China
|
Ming, Jian
|
|
|
41 |
8 |
p. 3138-3158
|
artikel
|
| 9 |
Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic Syndrome
|
Chang, Raymond C.
|
|
|
41 |
8 |
p. 3247-3263
|
artikel
|
| 10 |
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel Fumarate
|
Gudesblatt, Mark
|
|
|
41 |
8 |
p. 3059-3075
|
artikel
|
| 11 |
Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer
|
Ross, Ashley
|
|
|
41 |
8 |
p. 3076-3088
|
artikel
|
| 12 |
Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy
|
Perez de Isla, Leopoldo
|
|
|
41 |
8 |
p. 3407-3418
|
artikel
|
| 13 |
Diroximel Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: NEDA-3 After Re-Baselining in the Phase 3 EVOLVE-MS-1 Study
|
Bowen, James D.
|
|
|
41 |
8 |
p. 3396-3406
|
artikel
|
| 14 |
Effect of Hepatic Impairment on Trofinetide Exposures Using an In Silico Physiologically Based Pharmacokinetic Model
|
Darwish, Mona
|
|
|
41 |
8 |
p. 3328-3341
|
artikel
|
| 15 |
Effect of Pravastatin on Kidney Function in Patients with Dyslipidemia and Type 2 Diabetes Mellitus: A Multicenter Prospective Observational Study
|
Kim, Hae Jin
|
|
|
41 |
8 |
p. 3119-3137
|
artikel
|
| 16 |
Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study
|
Iff, Joel
|
|
|
41 |
8 |
p. 3278-3298
|
artikel
|
| 17 |
Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer
|
De Santis, Maria
|
|
|
41 |
8 |
p. 3039-3058
|
artikel
|
| 18 |
Imaging-Guided Percutaneous Endovascular Biopsy Applied in Patients with Pulmonary Artery Masses: A Review
|
Wu, Hongxia
|
|
|
41 |
8 |
p. 3028-3038
|
artikel
|
| 19 |
Impacts of X-linked Retinitis Pigmentosa and Patient Pathways in European Countries: Results from the Cross-sectional EXPLORE XLRP-1 Physician Survey
|
Pungor, Katalin
|
|
|
41 |
8 |
p. 3378-3395
|
artikel
|
| 20 |
Increased Risk of Severe Cardiovascular Events Following Exacerbations of Chronic Obstructive Pulmonary Disease: Results of the EXACOS-CV Study in Japan
|
Matsunaga, Kazuto
|
|
|
41 |
8 |
p. 3362-3377
|
artikel
|
| 21 |
Letter to the Editor Regarding “Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs”
|
Poggialini, Mauro
|
|
|
41 |
8 |
p. 3437-3438
|
artikel
|
| 22 |
Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma
|
Wu, James
|
|
|
41 |
8 |
p. 3232-3246
|
artikel
|
| 23 |
Quality of Life Evaluation in Patients with Follicular Cell Lymphoma: A Real-World Study in Europe and the United States
|
Johnson, Patrick Connor
|
|
|
41 |
8 |
p. 3342-3361
|
artikel
|
| 24 |
Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023—A Podcast
|
Costa, Luciano J.
|
|
|
41 |
8 |
p. 3017-3027
|
artikel
|
| 25 |
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy
|
Patel, Jyoti
|
|
|
41 |
8 |
p. 3299-3315
|
artikel
|
| 26 |
Real-World Treatment Patterns and Outcomes Across Three Lines of Therapy in Patients with ALK+ NSCLC
|
Arnaoutakis, Konstantinos
|
|
|
41 |
8 |
p. 3217-3231
|
artikel
|
| 27 |
Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson’s Disease: A Real-World Study
|
Barer, Yael
|
|
|
41 |
8 |
p. 3419-3425
|
artikel
|
| 28 |
Treatment Strategies for Filamentous Fungi Keratitis
|
Storr, Julia
|
|
|
41 |
8 |
p. 3316-3327
|
artikel
|
| 29 |
Usability of the SB11 Pre-filled Syringe (PFS) in Patients with Retinal Diseases
|
Lee, Yujin
|
|
|
41 |
8 |
p. 3426-3436
|
artikel
|
Tijdschrift beschrijving